Date: 13-09-2017 7:10PM
Source: Trivitron Healthcare
Category: General, Consumer Interest, Govt. & Public Policy, Social Issues, Healthcare & Biotechnology, Advertising, Pr And Marketing, Manufacturing Companies, Technology
Location: Chennai, Tamil Nadu, India
Business Wire IndiaTrivitron’s Labsystems Diagnostics Oy, a company that manufactures and develops high quality diagnostic tests for clinical laboratories and doctors, announced their collaboration with Baebies, a company focused on advancing newborn screening (NBS) and pediatric testing. September being the Newborn Screening awareness month, both the companies which are expert in innovative newborn screening products and services, have declared a joint bilateral distribution agreement to deliver a wider range of NBS solutions across several global markets.
Making a mark in their field and expanding their horizon, Baebies, a US based organization, will distribute Labsystems’ newborn screening products in the U.S. after obtaining regulatory clearance, while Labsystems will distribute Baebies’ SEEKER® platform internationally.
India has made significant improvements in detecting newborn diseases. Various initiatives for newborn screening programs have helped in developing the market, which has led to increase in awareness around newborn health. Government of India largely recommends for active New Born Screening across the country and individual states have to implement the New Born Screening Program in the respective states.
Trivitron’s Labsystems Diagnostics Oy, manufactures and develops high-quality diagnostic tests for clinical laboratories and doctors. Labsystems Diagnostics is a global leader in the field of newborn screening solutions with a complete range of neonatal screening test. NeoMass AAAC kit from Labsystems is used with Tandem Mass Spectrometry to detect concentrations of amino acids, free carnitine, acylcarnitines, succinylacetone and argininosuccinic acid.
“We are thrilled to add the SEEKER platform to our suite of newborn screening products. Overall this partnership will greatly benefit newborn screening labs across the world by providing a more comprehensive menu of newborn screening solutions for multiple types of assays,” said Nikhil Bedekar, President of Labsystems Diagnostics Oy.
“At this time, our newborn screening customers have only a single solution for many of their newborn screening tests. This exciting partnership allows us to offer the latest solutions and to provide a comprehensive offering to our growing customer base,” said Richard West, Co-founder and CEO of Baebies.
Labsystems and Baebies will be exhibiting together at the upcoming APHL Newborn Screening and Genetic Testing Symposium during September 10-13 in New Orleans, USA.
About Trivitron Healthcare
Labsystems Diagnostics is a subsidiary of Trivitron Healthcare Group, a globally acclaimed Medical technology solution company. Trivitron Healthcare strives to make healthcare technology accessible to all. Trivitron Healthcare offers solutions in In-Vitro Diagnostics, Newborn Screening, Imaging & Radiology, Radiology protection, OR, ICU, Renal care and Healthcare services.
Labsystems has been a forerunner in innovative diagnostic research and development for over the last 35+ years. Labsystems Diagnostics is committed to develop high-quality diagnostic solutions for clinical and research laboratories, and for consumer use. The company is dedicated to R&D investment, with highly qualified personnel and state of the art production. A highly rigorous quality system and CE-marked products ensure sustainable quality of the products. These assets combined with efficient customer support have meant long term customer satisfaction and a solid reputation for success. With 35+ years of experience, Labsystems Diagnostics has been a key pioneer in IVD and Newborn screening space.
For more information: www.trivitron.com | www.labsystemsdx.com